Igor Splawski
Igor Splawski, Winchester, MA US
Patent application number | Description | Published |
---|---|---|
20090175875 | Molecules and Methods for Modulating Complement Component - Compositions that bind to C3b epitopes and methods of using the compositions are described herein. | 07-09-2009 |
20100034809 | Compositions and Methods for Antibodies Targeting Complement Protein C5 - The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof. | 02-11-2010 |
20100291106 | COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING COMPLEMENT PROTEIN C3B - The present invention relates to antibodies and antigen binding fragments thereof that bind to both human and cynomolgus complement protein C3b, as well as compositions and methods of use thereof. | 11-18-2010 |
20130022615 | Compositions and Methods for Antibodies Targeting Complement Protein C5 - The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof. | 01-24-2013 |
20130064836 | Compositions and Methods for Antibodies Targeting Complement Protein C5 - The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof. | 03-14-2013 |
20130295102 | COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING FACTOR P - The present invention relates to antibodies or antigen binding fragments thereof that bind to complement Factor P and used thereof as well as combinations of anti-Factor P antibodies with antibodies or antigen binding fragments thereof that bind to complement component 5 (C5). | 11-07-2013 |
Igor Splawski, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20100166748 | C5 Antigens and Uses Thereof - The present invention pertains to the use of a complement inhibitor in methods of treatment of ocular disorders and the use of a complement inhibitor in the manufacture of a medicament in the treatment of an ocular disorder. | 07-01-2010 |
20140199306 | COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO - The present invention relates to compositions and methods for the inhibition of EPO. The invention provides antibodies and antigen binding fragments thereof that bind to EPO and are able to inhibit EPO-dependent cell proliferation and/or EPO-dependent cell signaling. | 07-17-2014 |